Filter
2523
Text search:
COVID-19
Impact
Featured
277
37
Language
Document type
1020
566
285
198
191
85
53
45
31
26
12
6
4
1
Countries
270
91
78
60
57
55
48
46
45
44
42
42
41
41
36
31
29
29
29
28
28
25
22
21
21
20
18
17
16
16
15
15
15
15
15
14
14
14
13
13
12
12
12
11
11
11
11
11
11
11
10
10
9
9
9
8
8
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
923
140
137
95
85
31
19
2
Toolboxes
1168
189
115
94
89
79
79
73
72
63
56
55
53
43
40
30
29
21
15
7
6
5
3
2
1
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis
...
COVID-19 Management Guide -Version June 2021
BMJ Open Science 2021;5:e100202. doi:10.1136/
bmjos-2021-100202
Updated Treatment Guidelines
INTRODUCTION: The COVID-19 pandemic has disrupted health systems around the world. The objectives of this study are to estimate the overall effect of the pandemic on essential health service use and
...
The Royal College of Paediatrics and Child Health recognises that climate change
is an existential threat to the health and wellbeing of children and young people.
In October 2020, we joined national health and academic alliances to declare
climate change an emergency requiring accelerated col
...
Guidelines on Management of COVID-19 in Kenya
recommended
It has been over a year since Kenya identified the first case of COVID-19 in the country. The Government formed the National COVID-
...
Consolidated recommendations for palliative care in the SARS pandemic-Cov-2/COVID-19 2020
Guidelines for diagnosis, acute care and post-COVID-19 follow-up for children and adolescents
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
Critical preparedness, readiness and response actions for COVID-19
Interim Guidance - 27 May 2021
WHO Information Leaflet COVID-19: Considerations on tuberculosis (TB) care
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19
...
English Analysis on World about Climate Change and Environment, Health and Epidemic; published on 03 Nov 2021 by World Bank
COVID-19 outbreak is associated with the generation of many types of infectious wastes, including infected masks, gloves and other protective equipment, together with a higher volume of general wast
...
Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence, Rapid Review 22 February 2022
recommended
This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically up
...
This guidance addresses rationale, risk-based scenarios, practical considerations prior to adoption of the self-testing products, quality assurance, safety and ethical considerations, and data management considerations for COVID-
...
